You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API bupivacaine and meloxicam

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing bupivacaine and meloxicam

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Heron Therapeutics Inc	ZYNRELEF	bupivacaine and meloxicam	47426-301	DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER	2035-04-20
Heron Therapeutics Inc	ZYNRELEF	bupivacaine and meloxicam	47426-301	DIMETHYL SULFOXIDE	2035-04-20
Heron Therapeutics Inc	ZYNRELEF	bupivacaine and meloxicam	47426-301	MALEIC ACID	2035-04-20
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for bupivacaine and meloxicam

Excipient focus: DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER

bupivacaine and meloxicam drug variants containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Heron Therapeutics Inc	bupivacaine and meloxicam	47426-301
>Company	>Ingredient	>NDC

bupivacaine and meloxicam drug variants not containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: DIMETHYL SULFOXIDE

bupivacaine and meloxicam drug variants containing DIMETHYL SULFOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Heron Therapeutics Inc	bupivacaine and meloxicam	47426-301
>Company	>Ingredient	>NDC

bupivacaine and meloxicam drug variants not containing DIMETHYL SULFOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MALEIC ACID

bupivacaine and meloxicam drug variants containing MALEIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Heron Therapeutics Inc	bupivacaine and meloxicam	47426-301
>Company	>Ingredient	>NDC

bupivacaine and meloxicam drug variants not containing MALEIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

bupivacaine and meloxicam drug variants containing TRIACETIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Heron Therapeutics Inc	bupivacaine and meloxicam	47426-301
>Company	>Ingredient	>NDC

bupivacaine and meloxicam drug variants not containing TRIACETIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.